Sernova Biotherapeutics (SEOVF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 10/31
| 07-2024 | 04-2024 | 01-2024 | 10-2023 | 07-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 3,665 | 2,532 | 4,818 | 6,466 | 13,321 |
| Marketable Securities | N/A | 3,712 | 6,691 | 8,218 | 9,936 |
| Receivables | 363 | 903 | 762 | 781 | 569 |
| TOTAL | $4,547 | $7,641 | $12,640 | $15,587 | $23,977 |
| Non-Current Assets | |||||
| PPE Net | 242 | 259 | 276 | 292 | 322 |
| Intangibles | 78 | 160 | 197 | 235 | 275 |
| Other Non-Current Assets | 577 | 606 | 633 | 277 | 305 |
| TOTAL | $897 | $1,025 | $1,106 | $803 | $902 |
| Total Assets | $5,444 | $8,665 | $13,746 | $16,390 | $24,879 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 14,175 | 12,267 | 10,439 | 7,011 | 7,314 |
| TOTAL | $14,246 | $12,335 | $10,504 | $7,112 | $7,433 |
| Non-Current Liabilities | |||||
| TOTAL | $362 | $384 | $404 | $N/A | $11 |
| Total Liabilities | $14,607 | $12,719 | $10,908 | $7,112 | $7,444 |
| Shareholders' Equity | |||||
| Common Shares | 81,261 | 81,762 | 82,142 | 82,286 | 83,163 |
| Retained earnings | -106,165 | -101,529 | -94,666 | -87,609 | -79,773 |
| TOTAL | $-9,163 | $-4,053 | $2,837 | $9,278 | $17,435 |
| Total Liabilities And Equity | $5,444 | $8,665 | $13,746 | $16,390 | $24,879 |